Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Omnicell Inc (OMCL)

Omnicell Inc (OMCL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,297,883
  • Shares Outstanding, K 42,763
  • Annual Sales, $ 897,030 K
  • Annual Income, $ 61,340 K
  • 60-Month Beta 0.93
  • Price/Sales 3.66
  • Price/Cash Flow 20.12
  • Price/Book 3.70

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate 0.31
  • Number of Estimates 2
  • High Estimate 0.31
  • Low Estimate 0.31
  • Prior Year 0.60
  • Growth Rate Est. (year over year) -48.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
66.20 +11.35%
on 09/01/20
78.19 -5.72%
on 09/18/20
+6.71 (+10.02%)
since 08/21/20
3-Month
62.24 +18.44%
on 07/14/20
78.19 -5.72%
on 09/18/20
+4.42 (+6.38%)
since 06/19/20
52-Week
54.24 +35.91%
on 03/20/20
94.85 -22.28%
on 02/07/20
-0.70 (-0.93%)
since 09/20/19

Most Recent Stories

More News
Pharmacy Automation Market Size 2020 - Industry Growth, Latest Trends, Technology Updates, Development Analysis, Production Cost, Top Players - BD, Cerner Corporation, Omnicell, Capsa Healthcare

Data Bridge Market Research (DBMR) has published a latest market research report on Pharmacy Automation Market. The global report is prepared in collaboration with the leading industry experts & dedicated...

CERN : 68.70 (-1.65%)
OMCL : 73.63 (-4.53%)
Omnicell to Present at Upcoming Investor Conferences

Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will present at the following upcoming investor conferences:...

OMCL : 73.63 (-4.53%)
Omnicell (OMCL) Down 7.7% Since Last Earnings Report: Can It Rebound?

Omnicell (OMCL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

OMCL : 73.63 (-4.53%)
Exclusive Set Of Companies Make Up Majority Of The Global Medication Adherence Market

According to The Business Research Company's research report, the global medication adherence market is concentrated, with a few large players holding a significant portion of the market share, while there...

CAH : 47.10 (-1.22%)
MCK : 148.23 (-2.56%)
OMCL : 73.63 (-4.53%)
QCOM : 111.92 (+1.11%)
Omnicell (OMCL) Hurt by Coronavirus-Led Lower Product Booking

Omnicell (OMCL) is currently witnessing slowdown in purchasing decisions by hospitals.

OMCL : 73.63 (-4.53%)
HOLX : 65.12 (+2.44%)
QGEN : 50.12 (-0.93%)
TMO : 425.47 (-0.83%)
DoseID Launches to Expand RFID Interoperability and Performance in Healthcare

Today marks the launch of DoseID, the first member driven industry consortium for the use of radio-frequency identification (RFID) technology in the healthcare space. DoseID offers best practices for using...

OMCL : 73.63 (-4.53%)
Omnicell, Pharmaceutical Strategies Enter Acquisition Deal

Omnicell (OMCL) expands pharmacy supply chain capabilities for better management of 340B programs through the buyout of PSG's 340B Link business.

OMCL : 73.63 (-4.53%)
HOLX : 65.12 (+2.44%)
QGEN : 50.12 (-0.93%)
TMO : 425.47 (-0.83%)
Peninsula Regional Medical Center Extends Partnership With Omnicell to Enhance Safety and Efficiency in Sterile Compounding

Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Maryland-based Peninsula Regional Medical...

OMCL : 73.63 (-4.53%)
Southeastern Grocers Offers Contactless Prescription Delivery and Expands Commitment to Customer Safety

--

OMCL : 73.63 (-4.53%)
Omnicell to Acquire Pharmaceutical Strategy Group's Leading 340B Software-Enabled Service Business

--Accelerates Omnicell's strategic transformation to support the vision of the fully Autonomous Pharmacy, building on the recent launch of Omnicell One

OMCL : 73.63 (-4.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade OMCL with:

Business Summary

Omnicell, Inc. is a leading provider of medication and supply management automation, analytics software, and medication adherence solutions for healthcare organizations. It works with healthcare providers to drive operational efficiency by removing tedious tasks and waste. Regardless of distribution...

See More

Key Turning Points

2nd Resistance Point 79.27
1st Resistance Point 78.19
Last Price 73.63
1st Support Level 76.04
2nd Support Level 74.97

See More

52-Week High 94.85
Fibonacci 61.8% 79.34
Fibonacci 50% 74.54
Last Price 73.63
Fibonacci 38.2% 69.75
52-Week Low 54.24

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar